{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T06:20:07Z","timestamp":1789885207245,"version":"4.0.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Radiation Oncology"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.semradonc.2011.05.002","type":"journal-article","created":{"date-parts":[[2011,9,20]],"date-time":"2011-09-20T09:41:52Z","timestamp":1316511712000},"page":"271-277","source":"Crossref","is-referenced-by-count":86,"title":["Radiation Therapy for Hepatocellular Carcinoma"],"prefix":"10.1016","volume":"21","author":[{"given":"Mary","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar","family":"Ben-Josef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semradonc.2011.05.002_bib1","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/ijc.1440","article-title":"Estimating the world cancer burden: Globocan 2000","volume":"94","author":"Parkin","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1016\/j.semradonc.2011.05.002_bib2","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1053\/j.gastro.2004.09.013","article-title":"Hepatocellular carcinoma: Recent trends in the United States","volume":"127","author":"El-Serag","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.semradonc.2011.05.002_bib3","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0039-6109(03)00227-5","article-title":"Modern hepatic imaging","volume":"84","author":"Braga","year":"2004","journal-title":"Surg Clin North Am"},{"key":"10.1016\/j.semradonc.2011.05.002_bib4","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/lt.20357","article-title":"Improving the prediction of hepatocellular carcinoma in cirrhotic patients with an arterially-enhancing liver mass","volume":"11","author":"Marrero","year":"2005","journal-title":"Liver Transplant"},{"key":"10.1016\/j.semradonc.2011.05.002_bib5","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/hep.510290145","article-title":"Natural history of untreated nonsurgical hepatocellular carcinoma: Rationale for the design and evaluation of therapeutic trials","volume":"29","author":"Llovet","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.semradonc.2011.05.002_bib6","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/jhep.2002.32089","article-title":"Prognostic prediction and treatment strategy in hepatocellular carcinoma","volume":"35","author":"Bruix","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.semradonc.2011.05.002_bib7","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1053\/jhep.2001.23561","article-title":"Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis","volume":"33","author":"Jonas","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.semradonc.2011.05.002_bib8","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","article-title":"Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis","volume":"334","author":"Mazzaferro","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semradonc.2011.05.002_bib9","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1053\/jhep.2002.33156","article-title":"Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma","volume":"35","author":"Lo","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.semradonc.2011.05.002_bib10","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/S0140-6736(02)08649-X","article-title":"Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: A randomised controlled trial","volume":"359","author":"Llovet","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.semradonc.2011.05.002_bib11","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semradonc.2011.05.002_bib12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(08)70285-7","article-title":"Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: A phase III randomised, double-blind, placebo-controlled trial","volume":"10","author":"Cheng","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.semradonc.2011.05.002_bib13","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S0360-3016(97)00550-6","article-title":"A phase I trial of hepatic arterial bromodeoxyuridine and conformal radiation therapy for patients with primary hepatobiliary cancers or colorectal liver metastases","volume":"39","author":"Robertson","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2011.05.002_bib14","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1200\/JCO.1998.16.6.2246","article-title":"Treatment of intrahepatic cancers with radiation doses based on a normal tissue complication probability model","volume":"16","author":"McGinn","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2011.05.002_bib15","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1200\/JCO.2000.18.11.2210","article-title":"Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies","volume":"18","author":"Dawson","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2011.05.002_bib16","doi-asserted-by":"crossref","first-page":"8739","DOI":"10.1200\/JCO.2005.01.5354","article-title":"Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies","volume":"23","author":"Ben-Josef","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2011.05.002_bib17","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0360-3016(02)02846-8","article-title":"Analysis of radiation-induced liver disease using the Lyman NTCP model","volume":"53","author":"Dawson","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2011.05.002_bib18","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.ijrobp.2006.06.015","article-title":"Feasibility and efficacy of high-dose three-dimensional-conformal radiotherapy in cirrhotic patients with small-size hepatocellular carcinoma non-eligible for curative therapies\u2014Mature results of the French phase II RTF-1 trial","volume":"66","author":"Mornex","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2011.05.002_bib19","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.ijrobp.2005.02.033","article-title":"Benefit of using biologic parameters (EUD and NTCP) in IMRT optimization for treatment of intrahepatic tumors","volume":"62","author":"Thomas","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2011.05.002_bib20","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1478-3231.2008.01873.x","article-title":"A multicenter retrospective cohort study of practice patterns and clinical outcome on radiotherapy for hepatocellular carcinoma in Korea","volume":"29","author":"Seong","year":"2009","journal-title":"Liver Int"},{"key":"10.1016\/j.semradonc.2011.05.002_bib21","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1002\/cncr.21012","article-title":"Hypofractionated three-dimensional conformal radiation therapy for primary liver carcinoma","volume":"103","author":"Liang","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.semradonc.2011.05.002_bib22","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/jjco\/hyh089","article-title":"Three-dimensional conformal radiation therapy for unresectable hepatocellular carcinoma patients who had failed with or were unsuited for transcatheter arterial chemoembolization","volume":"34","author":"Liu","year":"2004","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.semradonc.2011.05.002_bib23","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.ijrobp.2008.06.1486","article-title":"The treatment responses in cases of radiation therapy to portal vein thrombosis in advanced hepatocellular carcinoma","volume":"73","author":"Huang","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2011.05.002_bib24","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.radonc.2007.07.005","article-title":"Conformal radiation therapy for portal vein tumor thrombosis of hepatocellular carcinoma","volume":"84","author":"Toya","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.semradonc.2011.05.002_bib25","doi-asserted-by":"crossref","first-page":"861","DOI":"10.3109\/02841869509127197","article-title":"Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator","volume":"34","author":"Blomgren","year":"1995","journal-title":"Acta Oncol"},{"key":"10.1016\/j.semradonc.2011.05.002_bib26","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1080\/02841860600897934","article-title":"Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase I\u2013II study","volume":"45","author":"Mendez-Romero","year":"2006","journal-title":"Acta Oncol"},{"key":"10.1016\/j.semradonc.2011.05.002_bib27","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1200\/JCO.2007.14.3529","article-title":"Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma","volume":"26","author":"Tse","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2011.05.002_bib28","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s12094-010-0492-x","article-title":"Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma","volume":"12","author":"Cardenes","year":"2010","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.semradonc.2011.05.002_bib29","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1186\/1471-2407-10-475","article-title":"Long-term effect of stereotactic body radiation therapy for primary hepatocellular carcinoma ineligible for local ablation therapy or surgical resection","volume":"10","author":"Kwon","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.semradonc.2011.05.002_bib30","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/jso.21593","article-title":"Preliminary result of stereotactic body radiotherapy as a local salvage treatment for inoperable hepatocellular carcinoma","volume":"102","author":"Seo","year":"2010","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.semradonc.2011.05.002_bib31","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1177\/153303461000900506","article-title":"Stereotactic radiotherapy of hepatocellular carcinoma: Preliminary results","volume":"9","author":"Louis","year":"2010","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.semradonc.2011.05.002_bib32","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ijrobp.2005.12.031","article-title":"Radiation-induced liver disease in three-dimensional conformal radiation therapy for primary liver carcinoma: The risk factors and hepatic radiation tolerance","volume":"65","author":"Liang","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2011.05.002_bib33","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.radonc.2010.10.014","article-title":"Dosimetric predictor identification for radiation-induced liver disease after hypofractionated conformal radiotherapy for primary liver carcinoma patients with Child-Pugh grade A cirrhosis","volume":"98","author":"Liang","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.semradonc.2011.05.002_bib34","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.ijrobp.2009.09.009","article-title":"Stereotactic body radiotherapy for patients with unresectable primary hepatocellular carcinoma: Dose-volumetric parameters predicting the hepatic complication","volume":"78","author":"Son","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2011.05.002_bib35","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.ijrobp.2010.03.020","article-title":"Chest wall toxicity after stereotactic body radiotherapy for malignant lesions of the lung and liver","volume":"80","author":"Andolino","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2011.05.002_bib36","article-title":"Prediction of chest wall toxicity from lung stereotactic body radiotherapy (SBRT)","author":"Stephans","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2011.05.002_bib37","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1158\/1078-0432.CCR-04-1350","article-title":"Proton beam therapy for hepatocellular carcinoma: A retrospective review of 162 patients","volume":"11","author":"Chiba","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.semradonc.2011.05.002_bib38","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1259\/bjr\/33521596","article-title":"Combined therapy of transcatheter arterial chemoembolisation and three-dimensional conformal radiotherapy for hepatocellular carcinoma","volume":"80","author":"Zhou","year":"2007","journal-title":"Br J Radiol"},{"key":"10.1016\/j.semradonc.2011.05.002_bib39","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0360-3016(02)03929-9","article-title":"Clinical results and prognostic factors in radiotherapy for unresectable hepatocellular carcinoma: A retrospective study of 158 patients","volume":"55","author":"Seong","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2011.05.002_bib40","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00130404-200409000-00008","article-title":"A comparison of chemoembolization combination with and without radiotherapy for unresectable hepatocellular carcinoma","volume":"10","author":"Zeng","year":"2004","journal-title":"Cancer J"},{"key":"10.1016\/j.semradonc.2011.05.002_bib41","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.1097\/01.COC.0000077936.97997.AB","article-title":"Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma","volume":"26","author":"Li","year":"2003","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.semradonc.2011.05.002_bib42","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.3748\/wjg.v9.i8.1697","article-title":"Comparison between chemoembolization combined with radiotherapy and chemoembolization alone for large hepatocellular carcinoma","volume":"9","author":"Guo","year":"2003","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.semradonc.2011.05.002_bib43","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0360-3016(00)00462-4","article-title":"Local radiotherapy with or without transcatheter arterial chemoembolization for patients with unresectable hepatocellular carcinoma","volume":"47","author":"Cheng","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2011.05.002_bib44","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ijrobp.2009.07.1730","article-title":"Combination of transarterial chemoembolization and three-dimensional conformal radiotherapy for hepatocellular carcinoma with inferior vena cava tumor thrombus","volume":"78","author":"Koo","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2011.05.002_bib45","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1111\/j.1478-3231.2005.01170.x","article-title":"Local radiotherapy as a complement to incomplete transcatheter arterial chemoembolization in locally advanced hepatocellular carcinoma","volume":"25","author":"Shim","year":"2005","journal-title":"Liver Int"},{"key":"10.1016\/j.semradonc.2011.05.002_bib46","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.radonc.2008.11.002","article-title":"Transcatheter arterial chemoembolization in combination with radiotherapy for unresectable hepatocellular carcinoma: A systematic review and meta-analysis","volume":"92","author":"Meng","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.semradonc.2011.05.002_bib47","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/PL00012067","article-title":"Results of combined treatment with transcatheter hepatic arterial chemoembolization and whole-liver irradiation with the moving strip technique in unresectable hepatocellular carcinoma","volume":"5","author":"Wang","year":"2000","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.semradonc.2011.05.002_bib48","doi-asserted-by":"crossref","first-page":"5117","DOI":"10.1002\/cncr.24552","article-title":"Accelerated treatment using intensity-modulated radiation therapy plus concurrent capecitabine for unresectable hepatocellular carcinoma","volume":"115","author":"McIntosh","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.semradonc.2011.05.002_bib49","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/01.coc.0000239147.60196.11","article-title":"Three-dimensional conformal radiotherapy of unresectable hepatocellular carcinoma patients for whom transcatheter arterial chemoembolization was ineffective or unsuitable","volume":"29","author":"Kim","year":"2006","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.semradonc.2011.05.002_bib50","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ijrobp.2008.08.021","article-title":"Combined-modality therapy with gemcitabine and radiation therapy as a bladder preservation strategy: Long-term results of a phase I trial","volume":"74","author":"Oh","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2011.05.002_bib51","article-title":"Cyberknife stereotactic body radiation therapy for nonresectable tumors of the liver: Preliminary results","volume":"309780","author":"Goyal","year":"2010","journal-title":"HPB Surg"},{"key":"10.1016\/j.semradonc.2011.05.002_bib52","series-title":"Gastrointestinal Cancers Symposium","article-title":"SBRT outcomes for primary and metastatic liver lesions","author":"Stenmark","year":"2011"}],"container-title":["Seminars in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053429611000440?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053429611000440?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,16]],"date-time":"2019-06-16T01:31:45Z","timestamp":1560648705000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053429611000440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S1053429611000440"],"URL":"https:\/\/doi.org\/10.1016\/j.semradonc.2011.05.002","relation":{},"ISSN":["1053-4296"],"issn-type":[{"value":"1053-4296","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}